======= KIAA1244 ======= == Gene Information == * **Official Symbol**: ARFGEF3 * **Official Name**: ARFGEF family member 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=57221|57221]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q5TH69|Q5TH69]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KIAA1244&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KIAA1244|Open PubMed]] * **OMIM**: [[https://omim.org/entry/617411|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Participates in the regulation of systemic glucose homeostasis, where it negatively regulates insulin granule biogenesis in pancreatic islet beta cells (By similarity). Also regulates glucagon granule production in pancreatic alpha cells (By similarity). Inhibits nuclear translocation of the transcriptional coregulator PHB2 and may enhance estrogen receptor alpha (ESR1) transcriptional activity in breast cancer cells (PubMed:19496786). {ECO:0000250|UniProtKB:Q3UGY8, ECO:0000269|PubMed:19496786}. |DUF1981| |regulation of ARF protein signal transduction| |ARF guanyl-nucleotide exchange factor activity| |transport vesicle membrane| |negative regulation of phosphatase activity| |negative regulation of dephosphorylation| |regulation of phosphatase activity| |regulation of dephosphorylation| |regulation of Ras protein signal transduction| |regulation of small GTPase mediated signal transduction| |negative regulation of hydrolase activity| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of catalytic activity| |negative regulation of molecular function| |regulation of hydrolase activity| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of intracellular signal transduction| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp23|Nocodazole 0.02μM R00 exp23]]|-1.87| |[[:results:exp8|Brefeldin A 0.02μM R00 exp8]]|-1.74| |[[:results:exp52|Ribavirin 10μM R01 exp52]]|1.81| ^Gene^Correlation^ |[[:human genes:p:prim1|PRIM1]]|0.513| |[[:human genes:s:slco2b1|SLCO2B1]]|0.4| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18773 * **Expression level (log2 read counts)**: 1.74 {{:chemogenomics:nalm6 dist.png?nolink |}}